electronRx Limited
electronRx delivers clinically validated digital biomarkers and continuous patient insights across COPD, Asthma, Interstitial Lung Disease and Pulmonary Hypertension, accelerating drug development, patient stratification, and real world outcomes.
Based in Cambridge UK, we are a team of 20 highly experienced data scientists and software engineers, with a management team experienced working in the clinical, regulated pharmaceutical and healthcare sectors.
Our respiratory expertise allows us to work closely with clinical thought leaders on the frontlines of technological discovery in healthcare to develop novel ways to unlock previously inaccessible health insights and enable the industry-wide shift to value-based care.
The answer to reducing overcrowding in Emergency Departments and the 8am race for a GP appointment lies with the patient. We see all too often patients in a state of heightened anxiety, visiting the Emergency Department to then be released without further intervention in a matter of hours. Why? It is because they do not understand how to manage their condition. Asthma is a costly example of this. Many of the thousands of admissions to the ED every month are completely unnecessary, with many patients being released with no more intervention than the reassurance of the nurse or consultant. electronRx has been working to create a technology that gives the patient the required understanding of their condition, providing them with the ability to monitor essential bio-signs -much like diabetic patients can monitor their blood sugar - allowing them to manage their condition with correctly administered interventions, such as the use of an inhaler
